Cargando…

Dual HER2 Blockade: An Emerging Option in Metastatic Biliary Tract Cancer?

Detalles Bibliográficos
Autores principales: Ricci, Angela Dalia, Rizzo, Alessandro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8706370/
https://www.ncbi.nlm.nih.gov/pubmed/34946246
http://dx.doi.org/10.3390/medicina57121301
_version_ 1784622176159137792
author Ricci, Angela Dalia
Rizzo, Alessandro
author_facet Ricci, Angela Dalia
Rizzo, Alessandro
author_sort Ricci, Angela Dalia
collection PubMed
description
format Online
Article
Text
id pubmed-8706370
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-87063702021-12-25 Dual HER2 Blockade: An Emerging Option in Metastatic Biliary Tract Cancer? Ricci, Angela Dalia Rizzo, Alessandro Medicina (Kaunas) Commentary MDPI 2021-11-27 /pmc/articles/PMC8706370/ /pubmed/34946246 http://dx.doi.org/10.3390/medicina57121301 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Commentary
Ricci, Angela Dalia
Rizzo, Alessandro
Dual HER2 Blockade: An Emerging Option in Metastatic Biliary Tract Cancer?
title Dual HER2 Blockade: An Emerging Option in Metastatic Biliary Tract Cancer?
title_full Dual HER2 Blockade: An Emerging Option in Metastatic Biliary Tract Cancer?
title_fullStr Dual HER2 Blockade: An Emerging Option in Metastatic Biliary Tract Cancer?
title_full_unstemmed Dual HER2 Blockade: An Emerging Option in Metastatic Biliary Tract Cancer?
title_short Dual HER2 Blockade: An Emerging Option in Metastatic Biliary Tract Cancer?
title_sort dual her2 blockade: an emerging option in metastatic biliary tract cancer?
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8706370/
https://www.ncbi.nlm.nih.gov/pubmed/34946246
http://dx.doi.org/10.3390/medicina57121301
work_keys_str_mv AT ricciangeladalia dualher2blockadeanemergingoptioninmetastaticbiliarytractcancer
AT rizzoalessandro dualher2blockadeanemergingoptioninmetastaticbiliarytractcancer